| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ffa9d56881d8bb8ba8dee6267cceb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-968
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-804 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
1993-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94f3e407f855b7195a001944f27b1010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f24aff99c6fb20fa49558ae0aae616f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bc2a6c9ac4c8c2db0a3b097ffb31055 |
| publicationDate |
1993-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9321944-A1 |
| titleOfInvention |
Methods of treating cancer using modified c-reactive protein |
| abstract |
The invention provides a method of treating cancer in a mammal comprising administering to the mammal an effective amount of modified C-reactive protein ('mCRP'). The invention also provides a method of treating cancer in a mammal comprising administering to the mammal mCRP in combination with another agent such as a chemotherapeutic compound, immunoadjuvant, or cytokine. The mCRP may be administered to the mammal in a pharmaceutically-acceptable carrier or in liposomes. The invention further provides a method of identifying cancer cells in a mammal using mCRP as an imaging agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5874238-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5547931-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0667785-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0616535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0667785-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0616535-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1112081-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1112081-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6455046-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6190670-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6280743-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5939529-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6703219-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0011207-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6051415-A |
| priorityDate |
1992-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |